DE2946563A1 - Aminosaeureloesung zur parenteralen infusion - Google Patents

Aminosaeureloesung zur parenteralen infusion

Info

Publication number
DE2946563A1
DE2946563A1 DE19792946563 DE2946563A DE2946563A1 DE 2946563 A1 DE2946563 A1 DE 2946563A1 DE 19792946563 DE19792946563 DE 19792946563 DE 2946563 A DE2946563 A DE 2946563A DE 2946563 A1 DE2946563 A1 DE 2946563A1
Authority
DE
Germany
Prior art keywords
parts
weight
amino acid
arginine
ornithine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19792946563
Other languages
German (de)
English (en)
Other versions
DE2946563C2 (US07922777-20110412-C00004.png
Inventor
Antrag Auf Nichtnennung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KNAUFF, HANS-GEORG, PROF., VANCOUVER, BRITISH COLU
Original Assignee
B Braun Melsungen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Braun Melsungen AG filed Critical B Braun Melsungen AG
Priority to DE19792946563 priority Critical patent/DE2946563A1/de
Publication of DE2946563A1 publication Critical patent/DE2946563A1/de
Application granted granted Critical
Publication of DE2946563C2 publication Critical patent/DE2946563C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19792946563 1979-11-17 1979-11-17 Aminosaeureloesung zur parenteralen infusion Granted DE2946563A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19792946563 DE2946563A1 (de) 1979-11-17 1979-11-17 Aminosaeureloesung zur parenteralen infusion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792946563 DE2946563A1 (de) 1979-11-17 1979-11-17 Aminosaeureloesung zur parenteralen infusion

Publications (2)

Publication Number Publication Date
DE2946563A1 true DE2946563A1 (de) 1981-05-21
DE2946563C2 DE2946563C2 (US07922777-20110412-C00004.png) 1987-04-30

Family

ID=6086332

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19792946563 Granted DE2946563A1 (de) 1979-11-17 1979-11-17 Aminosaeureloesung zur parenteralen infusion

Country Status (1)

Country Link
DE (1) DE2946563A1 (US07922777-20110412-C00004.png)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3223150A1 (de) * 1981-06-23 1982-12-30 Pierrel S.p.A., Napoli Aminosaeuregemische, verfahren zu deren herstellung
DE3302008A1 (de) * 1982-01-22 1983-07-28 Ajinomoto Co., Inc., Tokyo Elementare diaet
EP0109439A1 (en) * 1982-05-17 1984-05-30 Univ Columbia AMINO ACID SOLUTIONS FOR PARENTERAL NUTRITION AS WELL AS METHOD OF DOSAGE AND USE.
FR2556593A1 (fr) * 1983-12-20 1985-06-21 Synthelabo Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels
EP0147682A1 (en) * 1983-12-05 1985-07-10 Ajinomoto Co., Inc. Novel amino acid infusion solution
EP0399341A1 (de) * 1989-05-24 1990-11-28 LEOPOLD PHARMA GESELLSCHAFT m.b.H. Wässrige Zusammensetzung für die parenterale Ernährung
EP0561141A1 (en) * 1992-03-20 1993-09-22 Clintec Nutrition Company Highly concentrated amino acid solution
FR2711529A1 (fr) * 1993-10-28 1995-05-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
WO1997005862A2 (en) * 1995-08-03 1997-02-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of basic amino acids and derivatives for lowering ceramide levels

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3821043A1 (de) * 1988-06-22 1989-12-28 Fresenius Ag Dialysier- und spuel-loesung zur intraperitonealen verabreichung

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556100A1 (de) * 1975-02-03 1976-08-05 American Hospital Supply Corp Aminosaeurepraeparate fuer leberkranke patienten
DE2531204A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2618099A1 (de) * 1976-04-26 1977-11-03 Fresenius Chem Pharm Ind L-aminosaeurengemische fuer die behandlung von leberinsuffizienz
DE2936236A1 (de) * 1978-09-08 1980-03-20 Ajinomoto Kk Aminosaeureloesung fuer die intravenoese ernaehrung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556100A1 (de) * 1975-02-03 1976-08-05 American Hospital Supply Corp Aminosaeurepraeparate fuer leberkranke patienten
DE2531204A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2618099A1 (de) * 1976-04-26 1977-11-03 Fresenius Chem Pharm Ind L-aminosaeurengemische fuer die behandlung von leberinsuffizienz
DE2936236A1 (de) * 1978-09-08 1980-03-20 Ajinomoto Kk Aminosaeureloesung fuer die intravenoese ernaehrung

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3223150A1 (de) * 1981-06-23 1982-12-30 Pierrel S.p.A., Napoli Aminosaeuregemische, verfahren zu deren herstellung
DE3302008A1 (de) * 1982-01-22 1983-07-28 Ajinomoto Co., Inc., Tokyo Elementare diaet
EP0109439A1 (en) * 1982-05-17 1984-05-30 Univ Columbia AMINO ACID SOLUTIONS FOR PARENTERAL NUTRITION AS WELL AS METHOD OF DOSAGE AND USE.
EP0109439A4 (en) * 1982-05-17 1986-06-05 Univ Columbia AMINO ACID SOLUTIONS FOR PARENTERAL NUTRITION AS WELL AS DOSING METHOD AND USE.
EP0147682A1 (en) * 1983-12-05 1985-07-10 Ajinomoto Co., Inc. Novel amino acid infusion solution
EP0146474A3 (fr) * 1983-12-20 1985-07-31 Synthelabo Composition nutritive contenant de l'acide alpha-cétoisocaproique ou un de ses sels
EP0146474A2 (fr) * 1983-12-20 1985-06-26 Synthelabo Composition nutritive contenant de l'acide alpha-cétoisocaproique ou un de ses sels
FR2556593A1 (fr) * 1983-12-20 1985-06-21 Synthelabo Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels
EP0399341A1 (de) * 1989-05-24 1990-11-28 LEOPOLD PHARMA GESELLSCHAFT m.b.H. Wässrige Zusammensetzung für die parenterale Ernährung
EP0561141A1 (en) * 1992-03-20 1993-09-22 Clintec Nutrition Company Highly concentrated amino acid solution
FR2711529A1 (fr) * 1993-10-28 1995-05-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
EP0655244A1 (fr) * 1993-10-28 1995-05-31 Clintec Nutrition Company Composition à base d'acides aminés pour le traitement d'infections
WO1997005862A2 (en) * 1995-08-03 1997-02-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of basic amino acids and derivatives for lowering ceramide levels
WO1997005862A3 (en) * 1995-08-03 1997-04-17 Sigma Tau Ind Farmaceuti Use of basic amino acids and derivatives for lowering ceramide levels

Also Published As

Publication number Publication date
DE2946563C2 (US07922777-20110412-C00004.png) 1987-04-30

Similar Documents

Publication Publication Date Title
DE68905387T2 (de) Aminosäure-Nahrungsmittelzusammensetzungen.
DE3875322T2 (de) Aminosaeure-zusammensetzung als traeger fuer die parenterale ernaehrung.
DE2556100C2 (US07922777-20110412-C00004.png)
DE3302008A1 (de) Elementare diaet
CH642541A5 (de) Essentielle aminosaeuren enthaltende loesung zur verabreichung an krebspatienten.
DE2936236A1 (de) Aminosaeureloesung fuer die intravenoese ernaehrung
DE69002201T2 (de) Formulierung zur Behandlung der Nierenkrankheiten.
DE2946563A1 (de) Aminosaeureloesung zur parenteralen infusion
DE2921312A1 (de) Pharmazeutisches mittel und dessen verwendung bei einer vollstaendig parenteralen ernaehrung
DE3037479A1 (de) Pharmazeutische zusammensetzung zur parenteralen ernaehrung aus l-carnitin oder acyl-l-carnitinen
EP0370994B1 (de) Behandlung von durch Glucose ausgelöster Quervernetzung von Collagen bei Diabetes mellitus-Patienten durch Arginin, Spermidin, Kreatin oder Agmatin
DE3117948C2 (de) Tripeptide und diese Verbindungen enthaltende Arzneimittel
Filipponi et al. A new surgical model of acute liver failure in the pig: experimental procedure and analysis of liver injury
DE69733207T2 (de) Verfahren zur hemmung von elf5a-biosynthese
DE2516027A1 (de) Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper
DE2335216A1 (de) Arzneimittel zur foerderung der proteinsynthese und zur unterdrueckung der harnstoffbildung
DE68910126T2 (de) Nahrungsmittelzusammensetzung.
DE2712777A1 (de) Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper
EP0234186A1 (de) Verwendung von Oligopeptiden zur Behandlung von cerebralen Störungen
DE2303463C2 (de) Aminosäuren-Fett-Kohlehydrat-Infusionsemulsion
DE10228680A1 (de) Grundlage für transdermale Formulierungen (PTF)
DE2944341A1 (de) Aminosaeuren enthaltendes pharmazeutisches praeparat
DE2636828C2 (US07922777-20110412-C00004.png)
CH639247A5 (de) Aminosaeuren und mineralsalze enthaltende infusionsloesung.
DE3414491A1 (de) L-aminosaeurengemische fuer die parenterale und orale anwendung bei nierenerkrankungen

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8327 Change in the person/name/address of the patent owner

Owner name: KNAUFF, HANS-GEORG, PROF., VANCOUVER, BRITISH COLU

8328 Change in the person/name/address of the agent

Free format text: FUCHS, J., DR.-ING. DIPL.-ING. B.COM. LUDERSCHMIDT, W., DIPL.-CHEM. DR.PHIL.NAT., PAT.-ANW., 6200 WIESBADEN

8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8339 Ceased/non-payment of the annual fee